Correlation Between Walker Dunlop and Innovation Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Innovation Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Innovation Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Innovation Pharmaceuticals, you can compare the effects of market volatilities on Walker Dunlop and Innovation Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Innovation Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Innovation Pharmaceuticals.
Diversification Opportunities for Walker Dunlop and Innovation Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Walker and Innovation is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Innovation Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovation Pharmaceuticals and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Innovation Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovation Pharmaceuticals has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Innovation Pharmaceuticals go up and down completely randomly.
Pair Corralation between Walker Dunlop and Innovation Pharmaceuticals
Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the Innovation Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Walker Dunlop is 45.26 times less risky than Innovation Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Innovation Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 0.05 in Innovation Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.02) from holding Innovation Pharmaceuticals or give up 40.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Walker Dunlop vs. Innovation Pharmaceuticals
Performance |
| Timeline |
| Walker Dunlop |
| Innovation Pharmaceuticals |
Walker Dunlop and Innovation Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Innovation Pharmaceuticals
The main advantage of trading using opposite Walker Dunlop and Innovation Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Innovation Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovation Pharmaceuticals will offset losses from the drop in Innovation Pharmaceuticals' long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Innovation Pharmaceuticals vs. Cytodyn | Innovation Pharmaceuticals vs. Decision Diagnostics | Innovation Pharmaceuticals vs. Vystar Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |